Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Medentum Innovations promotes health equity and transforming healthcare through affordable, high-performance point-of-care devices.
Center for Justice Research is a research center devoted to data-driven solutions for an equitable criminal justice system.
Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
Viora Health is a tech-enabled human centered program that wraps around the care management to engage patients in their own communities
Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.
Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Fesarius Therapeutics is to develop engineered skin replacement products.
Linshom is first to deliver an AI enabled, wearable, FDA cleared, operating room quality respiratory profile to the patient bedside.
Diagmetrics is a provider of mask-based diagnostic systems that aim to democratize testing and convert breath vapor into a fluid biosample.
iMetabolic Biopharma Corporation is a Biotechnology company.
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Advent Therapeutics is focused on providing therapies for micro-orphan applications.
Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
7 Generation Games makes educational video games and the tools to develop them.
Domus Diagnostics provides a care diagnostics platform that offers respiratory disease home testing services.
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research.
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Oncospherix is the culmination of a multi-year research program for cancer.
Jigsawdio is a women owned platform designed to help people with memory loss.
Wearable rehabilitation robotics
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 31 different industry categories.
Among tracked funding rounds, Cell Microsystems received $6.5M in a Series B round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Partillion Bioscience, Medentum Innovations, Center for Justice Research, Strykagen, Greenstone Biosciences. These companies were founded in 2020 or later.